Cure My Disease

Don't miss your cure!

Home News About
Log in / Sign up
← Back to home

Changchun Bcht Biotechnology Co.

Clinical trials sponsored by Changchun Bcht Biotechnology Co., explained in plain language.

Not yet recruiting 2 Not yet finished but already full! 2
Sort by
  • First human test for new Triple-Threat booster shot

    ⭐️ VACCINE ⭐️ Not yet recruiting

    This is an early-stage study to check the safety and immune response of a new combined vaccine for adolescents and adults. The vaccine aims to protect against whooping cough (pertussis), diphtheria, and tetanus. Researchers will give different doses to 96 healthy volunteers aged …

    Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️

    Last updated Mar 27, 2026 12:37 UTC

  • First human test for Next-Gen flu shot begins

    ⭐️ VACCINE ⭐️ Not yet recruiting

    This is an early-stage study to check if a new flu vaccine, which includes a special ingredient called BK-01 adjuvant, is safe and can trigger a good immune response in healthy adults. Researchers will give the vaccine to 160 people and closely monitor them for any side effects f…

    Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️

    Last updated Mar 17, 2026 13:09 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Terms of use Contact us

This is a site from Cyber and Space